Methoxy PEG dithiol NHS - MW 10000 Da

Cat. No.: M163951
Disponibile su ordine
QUALITÀ & PUREZZA MW 10000 Da
Storage
Protected from light,Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
100mg
M163951-100mg
—
2 Disponibile

76,27€

90,16€
Salva 13,88 € (15.40%)
500mg
M163951-500mg
—
2 Disponibile
298,42€
Enter a quantity for the sizes you want to add.

Panoramica

Nanocs dithio NHS functionalized polyethylene glycol (PEG-S-S-NHS) is a reducing reagent cleavable and amine (-NH2) reactive PEG derivative that can be used to modify protein, peptide or any other material surfaces with their available amino groups. Dithiol-NHS esters react with primary amine groups at pH 7~8.5 to form stable amide bonds, meanwhile, disulfide bond can be cleaved by DTT, TCEP and other disulfide bond reducing reagents.

Specifiche

Specifiche e purezza
MW 10000 Da
Condizioni di conservazione di stoccaggio
Protected from light,Store at -20°C,Argon charged
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDataOggetto
G2207440G2207440Certificate of AnalysisApr 02, 2025 M163951
G2207441G2207441Certificate of AnalysisApr 02, 2025 M163951
B2208063B2208063Certificate of AnalysisFeb 10, 2022 M163951
Proprietà chimiche e fisiche
SensibilitàLight & Moisture sensitive
Domande frequenti e articoli
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No item-specific, tested application protocols are provided in the Product Data. General, literature-based workflows for similar PEG–NHS/thiol linkers are outlined below for research planning only.

  • Protein PEGylation via NHS:

    • Prepare protein in PBS or HEPES, pH 7.4 (avoid Tris/glycine). Chill and degas.
    • Dissolve the linker freshly in dry DMSO (10–50 mg/mL). Add to protein to achieve 2–10 molar equivalents per lysine target.
    • Incubate 0–4 °C for 30–90 min with gentle mixing. Quench remaining NHS with ethanolamine (pH 8.0), then desalt.
  • Cysteine-selective conjugation (thiol–maleimide):

    • Reduce and desalt target to expose free cysteines. Buffer at pH 6.8–7.2 with 1 mM EDTA.
    • Add maleimide-bearing partner to the thiol-functional PEG conjugate (or vice versa). Incubate 15–60 min at RT. Purify by SEC.
  • Gold surface functionalization:

    • Clean Au substrate, then immerse in 0.1–1 mM solution of the thiol-containing PEG conjugate in ethanol or DMF for 2–12 h under inert atmosphere. Rinse and dry.

These are non-item-specific outlines. Adjust stoichiometry/conditions based on the actual molecular weight and functional loading from the CoA/Spec Sheet.

Biological Roles

Item-specific biological data are not provided. The following describes general, literature-based roles of PEG linkers in biochemical contexts (non-clinical, research use only):

  • PEG as a biomaterials modifier: Methoxy-terminated PEG imparts hydrophilicity and steric stabilization, reducing nonspecific protein adsorption and cell adhesion on surfaces.
  • NHS–amine conjugation: Enables covalent attachment to lysine residues or N-termini on proteins/peptides, creating PEGylated conjugates with altered hydrodynamic radius and solution behavior.
  • Thiol functionalities: React selectively with cysteine residues or with maleimide/vinylsulfone partners, facilitating site-specific modification or crosslinking under mild conditions.
  • Multivalency/architecture: A “dithiol” element provides two –SH groups that can bridge or anchor to metallic surfaces (Au, Ag) or participate in thiol–ene crosslinking to assemble protein-repellent hydrogels.
  • Stability considerations: In biological buffers, NHS activation is transient (minutes–hours); thiols are oxidation-prone above neutral pH. Using degassed buffers with EDTA and conducting reactions promptly preserves functionality.

Note: No pharmacological or clinical attributes are claimed or implied. For sensitive biological systems, remove unreacted NHS/thiols via desalting or dialysis to minimize nonspecific reactions.

Buffer Applications

Item-specific buffer recommendations are not provided. The following are general, literature-based guidelines for working with NHS esters and thiol functionalities in aqueous media.

  • NHS–amine coupling buffers:

    • Preferred pH: 7.2–8.3 (higher pH accelerates both coupling and hydrolysis; pH 7.4–7.8 is a practical compromise).
    • Common systems: Phosphate (PBS), HEPES, or carbonate/bicarbonate. Avoid buffers containing primary or secondary amines (e.g., Tris, glycine) which compete with the intended amine target.
    • Ionic strength: 50–150 mM salt typically maintains protein stability.
    • Cosolvent: 10–30% v/v DMSO or DMF can improve solubility for hydrophobic substrates.
  • Thiol reaction buffers:

    • Maleimide coupling optimal at pH 6.5–7.5 to minimize maleimide hydrolysis and thiol oxidation.
    • Additives: 0.5–1 mM EDTA to chelate trace metals; degas buffers to reduce dissolved oxygen.
    • Reducing agents: Avoid DTT/TCEP during coupling to maintain free thiols on the linker; if needed, remove reductants by desalting immediately before conjugation.
  • Practical preparation (example, general):

    • PBS, pH 7.4: 10 mM phosphate, 137 mM NaCl, 2.7 mM KCl. Filter (0.22 µm), degas, and chill.
    • Carbonate buffer, pH 8.3: 50 mM NaHCO3/Na2CO3; prepare fresh and use promptly for NHS chemistry.

Always prepare working solutions immediately prior to use to minimize NHS hydrolysis.

Green Alternatives

Greener choices relate primarily to solvent and coupling strategies rather than the PEG linker itself. Below are general, literature-based considerations.

  • Solvent alternatives:

    • Replace DMF/NMP with DMSO, ethyl acetate, or water-rich buffer systems when compatible with substrate solubility and reaction rates.
    • Consider bio-based dipolar aprotics (e.g., Cyrene, propylene carbonate) as substitutes for DMF in some NHS-amine couplings.
  • Process adjustments:

    • Conduct NHS couplings at ambient temperature and near-neutral pH to limit side reactions and energy use.
    • Use minimal organic cosolvent (10–30%) with buffered water to reduce VOC load.
    • Employ solid-supported scavengers to reduce solvent volumes for purification.

Comparison (general; not item-specific):

  • DMF vs DMSO vs Aqueous buffer
    • EHS profile: DMF (reprotoxic concerns) > DMSO (benign but enhances dermal absorption) > Aqueous (best, but hydrolysis risk).
    • Reaction rate: Aqueous ≥ DMF ≥ DMSO for NHS–amine (case-dependent).
    • Hydrolysis of NHS: Aqueous > DMSO ≈ DMF; mitigate by rapid addition and immediate use.

Trade-offs:

  • Water-rich systems are greener but can reduce effective yield due to NHS hydrolysis; DMSO strikes a balance for many bioconjugations. Cyrene/PC may have viscosity/compatibility limitations.

For this SKU, no item-specific green certifications are provided in the Product Data.

Pharmaceutical Uses

No pharmacopeial status or item-specific pharmaceutical information is provided in the Product Data. The following reflects general, non-clinical, literature-based context for PEG linkers:

  • Role in development workflows (research only):
    • PEG linkers with NHS and thiol groups are used to prototype conjugation strategies for biomolecules (proteins, peptides, oligonucleotides) and surfaces, informing later-scale process design.
    • Methoxy-capped PEG segments are commonly incorporated to modulate solubility and reduce nonspecific interactions in delivery systems and diagnostic materials.
  • Excipient/formulation context:
    • PEG-based materials can act as hydrophilic spacers or surface modifiers in particles and device coatings; final excipient suitability requires defined MW, purity, and regulatory compliance (not specified here).
  • Manufacturing considerations:
    • Residual NHS and free thiols are typically quenched or removed post-reaction to ensure material stability.
    • Documentation such as residual solvent levels, bioburden, endotoxin, and metals would be required for GMP contexts—no such specifications are provided for this SKU.

Note: This product is designated “For research use only” in the Product Data and is not intended for human or veterinary use, clinical applications, or as a finished pharmaceutical excipient without additional qualification.

Physical Properties

Item-specific values from Product Data:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

General/literature characteristics for PEG–NHS/thiol linkers (non-item-specific):

  • Physical state: PEG linkers span from viscous oils to waxy/solid materials depending on PEG length (typical softening in the 20–60 °C range for low–mid MW; literature, varies with n).
  • Solubility: Highly soluble in water and polar organics (DMSO, DMF, acetone, alcohols); solubility in nonpolar solvents is limited but improves with longer PEGs (literature).
  • Partitioning: PEGylated materials exhibit low logP due to ether oxygens; thiol and NHS functionalities increase polarity and reactivity (literature trend).
  • pKa considerations: Thiol pKa typically ~8–10 (literature, depends on context); deprotonated thiolate more nucleophilic and more oxidation-prone.
  • NHS ester stability: Hydrolyzes in water with half-life dependent on pH, temperature, and solvent; faster at higher pH and temperature (literature). Aqueous half-lives at pH 7–8 commonly range from minutes to a few hours.
  • Hygroscopicity: PEG backbones can absorb moisture; NHS groups are moisture-sensitive (literature).

Practical implications (general):

  • Handle under dry, inert atmosphere to preserve NHS and free thiols.
  • Minimize exposure to base, heat, and moisture to avoid NHS hydrolysis and thiol oxidation to disulfides.

For exact numerical specifications (mp/bp/density/RI/UV cutoff), see the CoA/Spec Sheet for this SKU.

Quality and Grades

Item-specific grade/purity from Product Data:

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

What this means for use (general guidance for PEG linkers):

  • PEG linker quality is typically defined by:
    • Average molecular weight (Mn/Mw) and dispersity (Ð). Narrow distributions improve reproducibility in conjugations and materials performance.
    • Functional group content (mmol functional group per gram) and residual protecting groups/impurities. For NHS-activated linkers, hydrolysis content is critical.
    • Residual solvents and inorganic ash (particularly for applications in surface science/bioconjugation).
  • Stabilization and packaging:
    • This SKU is specified to be argon charged and light-protected, indicating sensitivity of NHS and thiols. Such packaging reduces hydrolysis and oxidation between manufacturing and end use.
  • Practical QC checks (user-side, general):
    • Titration of thiols (e.g., Ellman’s reagent) to confirm available –SH content.
    • NMR/FTIR to verify NHS ester integrity (succinimide carbonyls ~1810/1780 cm⁻¹; literature) and absence of significant hydrolysis.
    • SEC/GPC to assess PEG distribution, if relevant.

If your application requires a specific MW range, functional loading, or low UV absorbance (e.g., for optical work), confirm against the CoA/Spec Sheet and request lot-specific documentation.

Reaction and Applications

Applications (general/literature for methoxy-PEG linkers bearing NHS and thiols):

  • Bioconjugation:
    • NHS–amine coupling to introduce PEG onto proteins, peptides, or small molecules via lysine side chains/N-termini, forming stable amide (or carbamate) linkages.
    • Dual thiol handles enable:
      • Michael addition to maleimides/vinyl sulfones (site-selective cysteine conjugation on biomolecules).
      • Disulfide formation with activated disulfides for cleavable linkages.
      • Surface attachment on Au/Ag (thiol–metal chemisorption) for plasmonic/biosensor interfaces.
  • Materials/scaffolds:
    • Crosslinking through thiol–ene or thiol–yne click chemistry to form hydrogels or surface coatings while maintaining a methoxy-terminated, protein-repellent surface.
  • Nanomaterials:
    • PEGylation of nanoparticles (NHS to amine-functional shells; thiols for noble metal surfaces) to modulate colloidal stability and interfacial chemistry.

Practical tips (general):

  • Sequence orthogonal reactions to preserve functionality: perform NHS–amine coupling first (under anhydrous or mildly aqueous conditions) then proceed to thiol-specific modifications at neutral pH under inert atmosphere.
  • Include EDTA (0.5–1 mM) to limit metal-catalyzed thiol oxidation.
  • Use molar excesses of linker (1.1–5.0 equiv) to drive NHS reactions; monitor by LC/MS or TNBS assay for residual amines.
  • Minimize base and time in aqueous media to reduce NHS hydrolysis; prepare fresh solutions immediately before use.

Item-specific directions are not provided in the Product Data; consult application notes/CoA for this SKU for exact stoichiometries.

Reaction Conditions

The Product Data do not include tested conditions. The following are general, literature-derived guidelines for similar PEG–NHS/thiol linkers. Optimize for your system.

  • NHS–amine coupling:

    • Solvent: Anhydrous DMF or DMSO; or aqueous PBS/carbonate buffer pH 7.2–8.3 with 0–30% organic cosolvent.
    • Base: DIPEA (1–3 equiv) in aprotic media; avoid primary amine buffers in water.
    • Temperature/time: 0–25 °C, 15–120 min typical; colder temps reduce hydrolysis.
    • Stoichiometry: 1.1–5.0 equiv of NHS linker per amine site, depending on accessibility.
    • Monitoring: LC/MS, UV (disappearance of amine-reactive probe), TNBS or fluorescamine assays.
  • Thiol–maleimide conjugation:

    • Buffer: pH 6.5–7.5 (PBS/HEPES), 0.5–1 mM EDTA; degassed.
    • Temperature/time: 4–25 °C, 10–120 min.
    • Additives: Avoid excess base; if necessary, brief activation to thiolate (pH 7.5–8) followed by rapid reaction.
  • Thiol–ene click:

    • Solvent: Ethanol/water or DMF.
    • Initiation: Photoinitiator (e.g., LAP) under UV/visible light; temperature ambient; minutes to tens of minutes.
  • Disulfide formation/exchange:

    • Conditions: Mild oxidants (air, DMSO trace) or activating agents (DTNP) at neutral pH; monitor to avoid overoxidation.

Yields: Typically moderate to high (50–95%) for clean, unhindered substrates (literature-dependent). Purify by precipitation, dialysis, SEC, or ultrafiltration as appropriate.

Always prepare fresh solutions immediately before use to minimize NHS hydrolysis and thiol oxidation.

Safety and Handling

Item-specific hazard data from Product Data:

  • Signal Word: Not specified for this item; refer to SDS.
  • H-Statements: Not specified for this item; refer to SDS.
  • GHS Classification and Pictograms: Not specified for this item; refer to SDS.

Item-specific storage and shipping:

  • Storage: Store at −20 °C, protected from light, under argon (as provided). Keep container tightly closed.
  • Shipping: Ice chest + ice pads (provided), indicating temperature sensitivity.

General safety guidance for PEG–NHS/thiol linkers (literature/practice; defer to SDS):

  • Hazards: NHS esters are irritants; thiols can be malodorous and may cause skin/eye irritation. PEG backbone generally low toxicity but not hazard-free.
  • Special risks:
    • Hydrolysis: NHS ester reacts with moisture → carboxylate (or carbonate) and NHS; loss of activity.
    • Oxidation: Thiols oxidize to disulfides in air/at elevated pH; may diminish reactivity.
  • Incompatibilities: Avoid strong bases, nucleophilic amines (e.g., Tris) and aqueous buffers during storage; avoid oxidizers and metal salts that catalyze thiol oxidation.
  • PPE: Lab coat, safety glasses, and appropriate gloves (nitrile). Work in a fume hood when weighing/dissolving. Use inert gas purges for solution handling.
  • First aid (overview; consult SDS):
    • Skin/eye contact: Rinse with water for ≥15 min; remove contaminated clothing; seek medical attention if irritation persists.
    • Inhalation: Move to fresh air; seek medical advice if symptoms occur.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.

Waste: Collect solutions and contaminated disposables as organic hazardous waste; segregate thiol-containing wastes if required by local regulations.

Solvent Selection

General solvent behavior (literature/practice):

  • Polarity/miscibility: PEG-based linkers are typically highly soluble in polar aprotic solvents (DMSO, DMF, NMP, acetonitrile) and miscible with water. Solubility in alcohols (MeOH/EtOH/IPA) is usually good; limited in nonpolars (toluene/hexanes) unless PEG length is high.
  • Reactivity considerations:
    • NHS ester coupling to amines proceeds efficiently in anhydrous DMF/DMSO or in buffered aqueous media (pH 7.2–8.5). Water accelerates hydrolysis; balance solvent choice with reaction rate.
    • Thiol functionality is oxidation-sensitive; avoid prolonged basic aqueous conditions.

Selection tips (general):

  • For amine coupling (NHS):
    • Anhydrous DMF or DMSO with a non-nucleophilic base (DIPEA) for hydrophobic amines.
    • Aqueous PBS or phosphate-bicarbonate buffer (pH 7.4–8.3) for water-soluble amines; include organic cosolvent (10–30% DMF/DMSO) if needed.
  • For thiol chemistry:
    • Maleimide additions in PBS, pH 6.5–7.5, often with EDTA (0.5–1 mM) to chelate metals.
    • Thiol–gold/surface coupling in ethanol/water or DMF under inert atmosphere.

Compact comparison (general):

  • DMF: Maximizes NHS stability vs water; excellent solvation; toxic; hard to remove from bioconjugates.
  • DMSO: Biocompatible cosolvent; easy handling; can oxidize slowly; keep dry.
  • Aqueous buffers: Biorelevant; fastest amine coupling; highest NHS hydrolysis risk—prepare immediately before use.

Always dry solvents (molecular sieves/argon sparge) to protect NHS and thiols.

Storage and Reconstitution

Item-specific conditions from Product Data:

  • Storage: Store at −20 °C, protected from light, argon charged.
  • Shipped: In an ice chest with ice pads.

General recommendations (literature/practice) for PEG–NHS/thiol linkers:

  • Inert handling: Maintain anhydrous, oxygen-poor environment. Purge vials with argon/nitrogen after each use.
  • Aliquoting: Upon first opening, divide into single-use aliquots under dry argon to minimize freeze–thaw and headspace oxygen/moisture.
  • Reconstitution (non-item-specific):
    • Solvents: Dry DMSO or DMF are typical. Aqueous buffers (pH 7.2–7.8) can be used immediately before NHS coupling with minimal delay.
    • Concentration: Not specified for this item; refer to CoA/Spec Sheet. Prepare only what is needed for immediate use.
    • Filtration: If sterile work is required, filter solutions through 0.22 µm PTFE/PES into inert-gas–flushed vials.
  • Stability notes:
    • NHS hydrolyzes in water; keep aqueous solutions on ice and use within minutes–hours.
    • Thiols oxidize to disulfides; include EDTA (0.5–1 mM) in aqueous buffers and minimize exposure to air and base.
  • Disposal: Quench residual NHS with ethanolamine; dispose of solutions as organic hazardous waste per institutional guidelines.

For shelf-life, exact solvent compatibility, and any stabilizers, consult the lot-specific CoA/Spec Sheet and SDS.

Structure and Identity

Brief overview: This product name suggests a PEG-based heterobifunctional linker featuring a methoxy-capped PEG backbone bearing thiol functionality and an NHS-activated group for amine coupling.

  • Item-specific identifiers from Product Data:

    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general/literature-based description for “methoxy PEG dithiol NHS” type linkers):

    • Core: Poly(ethylene glycol) chain [–(CH2–CH2–O)–n–] providing hydrophilicity and flexibility.
    • End groups: One terminus methoxy-capped (–O–CH3; nonreactive, increases stealth/solubility).
    • Thiol functionality: Presence of two thiols (–SH), often positioned as terminal or pendant groups; capable of disulfide formation or Michael addition to maleimides/vinylsulfones.
    • NHS functionality: N‑hydroxysuccinimide (NHS) activated ester or carbonate enabling rapid coupling to primary amines to form stable amide (or carbamate) bonds.
    • 2D description in words: A linear PEG chain with one end blocked by methoxy, another site bearing an NHS-activated group, and two –SH groups available for thiol chemistry; no stereocenters in the PEG backbone, succinimide ring present in the NHS moiety.

Note: Exact architecture (placement of dithiols relative to the NHS site and PEG length n) is not specified in the Product Data and may vary by catalog sub-type. Consult the CoA/Spec Sheet for definitive structure and average MW.

Synthetic Utility

General, literature-based synthetic value of methoxy PEG linkers bearing NHS and thiols:

  • Functional group portfolio:

    • NHS-activated ester/carbonate: Fast acylation of primary amines to form amide/carbamate bonds under mild conditions; high chemoselectivity in the presence of alcohols/phenols.
    • Thiols (two): Nucleophilic and redox-active; undergo S-alkylation, Michael addition, disulfide exchange, thiol–ene/yne additions, and metal–thiolate coordination.
    • Methoxy cap: Inert terminus providing directionality and minimizing undesired crosslinking at one end of the PEG chain.
  • Orthogonality and sequence control:

    • Stage 1: NHS–amine coupling in anhydrous/aqueous media to attach PEG to a target scaffold.
    • Stage 2: Utilize thiols for site-specific ligation (maleimide/vinyl sulfone) or surface immobilization; or oxidize to disulfide to make cleavable crosslinks.
  • Retrosynthetic planning:

    • Treat the linker as a monofunctional PEG (mPEG) with additional thiol valency and an activated handle; enables modular assembly of multi-domain constructs (e.g., ligand–PEG–surface or amine-bearing cargo–PEG–dithiol).
  • Purification/workup strategies:

    • Exploit PEG’s phase behavior (liquid–liquid extraction with brine/EtOAc) or precipitate from cold ethers to separate from small molecules.
    • Remove NHS byproducts by aqueous washes or size-exclusion.

Item-specific loading (mmol/g) and MW, which drive stoichiometry and purification strategy, are not specified and should be taken from the CoA/Spec Sheet.

Target Specificity

Not applicable. This SKU is a chemical linker, not a biological affinity reagent. No target/epitope, clone, isotype, or species reactivity is defined in the Product Data.

Domande frequenti

How should this product be stored?
Store at ?20 °C, protected from light, under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.